Literature DB >> 2450568

Physical studies of Trypanosoma brucei variant surface glycoproteins and their antigenic determinants.

M W Clarke1, W D McCubbin, C M Kay, T W Pearson.   

Abstract

Secondary structure determinations have been carried out on two antigenically related variant surface glycoproteins (VSG's) from Trypanosoma brucei, WaTat 1.1 and WaTat 1.12. The two molecules, which bear highly homologous amino-terminal sequences, showed subtle differences in their circular dichroism (CD). Computer analysis revealed that the contribution of alpha helix to the secondary structure of the VSG's was 49% for WaTat 1.1 and 52% for WaTat 1.12. Unfolding studies using guanidine hydrochloride suggested that the WaTat 1.12 VSG was slightly more resistant than WaTat 1.1 VSG to the effect of this reagent. The membrane form of WaTat 1.1 VSG purified by reverse-phase high-performance liquid chromatography gave CD and fluorescence spectra indicative of a partially unfolded or denatured molecule. It was also shown that the antigenic differences between the VSG's were due to surface-oriented topographically assembled epitopes which were highly sensitive to structural perturbations. Monoclonal antibodies specific for these epitopes bound to four discreet determinants on WaTat 1.1, one of which was absent from WaTat 1.12.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450568     DOI: 10.1021/bi00401a061

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system.

Authors:  Melissa E Dubois; Karen P Demick; John M Mansfield
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Exposed epitopes on a Trypanosoma equiperdum variant surface glycoprotein altered by point mutations.

Authors:  T Baltz; C Giroud; F Bringaud; H Eisen; C Jacquemot; C W Roth
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.